eprintid: 11460
rev_number: 10
eprint_status: archive
userid: 2314
dir: disk0/00/01/14/60
datestamp: 2021-09-19 06:24:15
lastmod: 2021-09-19 06:24:15
status_changed: 2021-09-19 06:24:15
type: thesis
metadata_visibility: show
creators_name: Pandhita, Gea
creators_id: geapandhita@gmail.com
creators_orcid: 0000-0001-5206-2447
title: GAMBARAN QUANTITATIVE ELECTROENCEPHALOGRAPHY (QEEG)
SEBAGAI PREDIKTOR RESPON TERAPI METHYLPHENIDATE
DALAM PENATALAKSANAAN
ATTENTION-DEFICIT / HYPERACTIVITY DISORDER (ADHD) PADA ANAK
ispublished: unpub
subjects: R
subjects: R1
subjects: RZ
divisions: 11201
abstract: Background. ADHD is the most common neurobehavioral disorder of childhood,
and frequently encountered childhood-onset neurodevelopmental disorder. The
impact of ADHD on individual and society is enormous. Methylphenidate is the most
researched and prescribed pharmacological treatments for ADHD, but about 15 – 20
% of patients having no benefit. Few studies have investigated the use of QEEG
measurement in predicting which children with ADHD respond positively to
methylphenidate, but the result is not conclusive yet. The use of QEEG for predicting
outcome is based on the ability to identified the underlying cortical dysfunctions.
Objectives. To measure the role of QEEG profile in predicting which children with
ADHD respond positively to methylphenidate.
Methods. A historical cohort study base on consecutive children with ADHD of 4 –
15 years old that have recent diagnosed, and plan to receive methylphenidate in
P3TKA clinic. The predictor is QEEG profile that divided into two groups consisting
of cortically hypoaroused and non-hypoarousal. The primary outcome is respond
positively to methylphenidate over four weeks therapy.
Results. Subjects consisted of 19 girls (19,8%) and 77 boys (80,2%), with mean of
age is 8,33 ± 2,74 years old. ADHD patients consisted of 46,9% inattentive type, and
53,1% combined type of ADHD. The mean dose of methylphenidate is 0,42 mg/kg.
The predictors of good respond to methylphenidate are QEEG cortically
hypoaroused (RR = 2,02; 95% CI 1,72 – 4,22) and intelegensia (p = 0,02).
Conclusions. The QEEG cortically hypoaroused can be use to predict which
children with ADHD respond positively to methylphenidate.
Kata kunci: attention-deficit / hyperactivity disorder – methylphenidate –
quantitative electroencephalography – hypoarousal – predictor
date: 2005
date_type: published
full_text_status: public
pages: 29
institution: Gadjah Mada University
department: Departemen Ilmu Penyakit Saraf
thesis_type: masters
thesis_name: other
referencetext: 1. American Academi of Pediatrics, Committee on Quality Improvement, Subcommittee on
Attention-Deficit/Hyperactivity Disorder. Clinical Practice Guideline: Diagnosis and
Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder, Pediatrics, 2000,
vol. 105, no. 5
2. Brown T. R., Wendy S. F., James M. P., Martin T. S., Robert W. A., Heidi M. F., Karen
P., Mark L. W. Prevalence and Assessment of Attention-Deficit/Hyperactivity Disorder in
Primary Care Settings, Pediatrics, 2001, vol. 107, no. 3
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.
4th ed. Washington, DC, 1994
4. American Academi of Pediatrics, Committee on Quality Improvement, Subcommittee on
Attention-Deficit/Hyperactivity Disorder. Clinical Practice Guideline: Treatment of the
School-Aged Child With Attention-Deficit/Hyperactivity Disorder, Pediatrics, 2001, vol.
108, no. 4
5. Andres M. A. Prevalence, comorbidity, risk factors and service utilisation of disruptive
behaviour disorders in a community sample of children in Valencia (Spain). Soc
Psychiatry Psychiatr Epidemiol, 1999, 34:175-179
6. Green M., Wong M., Atkins D. Technical Review Number 3: Diagnosis of AttentionDeficit/Hyperactivity Disorder. Rockville, MD: Agency for Health Care Policy and
Research, US Department of Health and Human Services, AHCPR Publication 99-0050,
1999
7. Nava M., Barbero M. Epidemiological data about attention deficit hyperactivity disorder
in a sample of marabino children, Rev Neurol, 2003, November 1, 37(9): 815-9
8. Saputro D. Manajemen Terapi Gangguan Hiperkinetik / ADHD pada Anak dan Remaja,
makalah dalam Simposium Penatalaksanaan Masa Kini Ganggguan Pemusatan 
26
Perhatian / Hiperaktifitas, Bagian Ilmu Kesehatan Anak FK UGM / RS Dr. Sardjito,
Yogyakarta, 2001
9. Saputro D. Medikasi Gangguan Pemusata Perhatian dan Hiperaktivitas (GPPH / ADHD),
makalah dalam Panel Discussion Consensus on Medication Treatment of ADHD,
Konvensi Nasional Psikiatri Anak dan Remaja, Jakarta 5-6 Oktober, 2002
10. Spencer T., Biederman J., Wilens T. E., Faraone S. V. Adults with attentiondeficit/hyperactivity disorder: a controversial diagnosis, J Clin Psychiatry, 1998, 59:59-68
11. Biederman J., Faraone SV., Milberger S. Predictors of persistence and remissions of
ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad
Child Adolesc Psychiatry, 1996, 35:343–351
12. Goldman L., Genel M., Bezman R., Slanetz P. Diagnosis and treatment of attentiondeficit/hyperactivity disorder in children and adolescents, Council on Scientific Affairs,
Journal of American Medical Association, 1998, 279:1100-1107
13. Schachar R., Taylor E., Wieselberg M. B., Ghorley G., Rutter M. Changes in family
functioning and relationships in children who respond to methylphenidate, J Am Acad
Child Adolesc Psychiatry, 1987, 26:728–732
14. Zentall S. S. Research on the educational implications of attention deficit hyperactivity
disorder, Exceptional Child, 1993, 60:143–153
15. Miller A., Lee S., Raina P., Klasses A., Zupancic J., Olsen L. A review of therapies for
attention­deficit/hyperactivity disorder, Canadian Coordinating Office for Health
Technology Assessment, Ottawa, 1998
16. Poerwadi T. Attention Deficit Hyperactivity Disorder (ADHD), dalam Pendidikan
Kedokteran Berkelanjutan, Update on Neurology 2002, Lab/SMF Ilmu Penyakit Saraf FK
UNAIR / RSUD Dr. Soetomo, Surabaya, 2002
17. Simon H., Theodore A. S. Attention-Deficit Hyperactivity Disorder, Massachusetts
General Hospital, 2002
18. Swanson J. Compliance with Stimulants for Attention-Deficit/Hyperactivity Disorder
Issues and Approaches for Improvement, CNS Drugs, 2003, 17 (2): 117-131
19. Greenhill L. L., Pliszka S., Dulcan M. K. Practice parameter for the use of stimulant
medications in the treatment of children, adolescents, and adults, J Am Acad Child
Adolesc Psychiatry, 2002, 41 Suppl. 2: 26S-49S
20. Miller A. R., Christopher E. L., Kimberlyn M. M. G., Robert W. A. Prescription of
methylphenidate to children and youth, 1990–1996, CMAJ, 2001, 165(11):1489-94
21. Alvarez J. J. C., Barrientos C. R. Variability and tendencies in the consumption of
methylphenidate in Spain. An estimation of the prevalence of attention deficit
hyperactivity disorder, Rev Neurol, 2003, November 1, 37(9): 806-10
22. Clarke R. A., Robert J. B., Rory M. C., Mark S., Rodney J. C. EEG differences between
good and poor responders to methylphenidate in boys with the inattentive type of
attention-deficit/hyperactivity disorder, Clinical Neurophysiology, 2002, 113:1191–1198
23. Guevara J. P., Stein M. T. Evidence based paediatrics: Evidence based management of
attention deficit hyperactivity disorder, bmj, 2003, vol. 323(24)
24. Sacket D. L., Straus S. E., Richardson W. S., Rosenberg W., Haynes R. B. Evidence
based medicine: how to practice and teach ebm, oxford university press, 2001
25. Aman M. G., Kern R. A., Osborne P., Yumuluru R., Rojahn J., Medico V. Fenfluramine
and methylphenidate in children with mental retardation and borderline IQ: Clinical
effects, American Journal of Mental Retardation, 1997, 101:521-534
26. Denney C. B. Predictive models of methylphenidate response in children with AttentionDeficit Hyperactivity Disorder: Premises, implications, and an empirical evaluation.
Unpublished Ph.D. Dissertation, University of Hawaii, Honolulu, HI, 1997
27. Effron, Jarman, Barker. Methylphenidate versus dextroamphetamine in children with
attention deficit hyperactivity disorder: A double-blind, crossover trial, Pediatrics, 1997,
100(6), E6 
27
28. Gray J. R., Kagan J. The challenge of predicting which children with ADHD respond
positively to methylphenidate, Journal of Applied Developmental Psychology, 2000, (1),
20
29. Sunohara, Voros, Malone, Taylor. Effects of methylphenidate in children with attention
deficit hyperactivity disorder: a comparison of eventrelated potentials between
medication responders and non-responders, International Journal of Psychophysiology,
1997, 27, 9-14
30. Grace A. A. Psychostimulant actions on dopamine and limbic system function: relevance
to the pathophysiology and treatment of ADHD, dalam Stimulant Drugs and ADHD, eds
M. V. Solanto, A. F. Arnsten, & F. X. Castellanos, pp. 134-157, New York: Oxford
University Press, 2000
31. Clarke R. A. R., Robert J. B., Rory M. C., Mark S. EEG-defined subtypes of children with
attention-deficit/hyperactivity disorder, Clinical Neurophysiology, 112: 2098–2105, 2001
32. Schachter H. M, Ba’ Pham, Jim K., Stephanie L., David M.. How efficacious and safe is
shortacting methylphenidate for the treatment of attention-deficit disorder in children and
adolescents? A meta-analysis, CMAJ, 2001, 165(11):1475-88
33. Stein M. A., Christopher S. S., Irwin D. W., Adelaide S. R., Charles C., Phillip L. P.,
David O. B., Karen E. S., Jeffrey H. N. A Dose-Response Study of OROS
Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder, Pediatrics,
2003, Vol. 112 No. 5
34. Pelham W. E., Elizabeth M. G., Lisa B. M., Andy W., Gregory A. F., Sean M. M., Andrea
M. C., Gregory L. F., Celeste A. Ng., Martin T. H., Thomas M. L., Karl F., Erika K. C.,
Carlos J. P., Randi L. S., David L. M., Adia N. O., Gene D. M. Once-a-Day Concerta
Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural
Settings, Pediatrics, 2001, Vol. 107 No. 6
35. Purnomo M. S. W. Pengaruh Sikap Orang Tua sebagai Faktor Resiko Perkembangan
Gangguan Pemusatan Perhatian / Hiperaktivitas pada Murid Sekolah Dasar di
Yogyakarta, Bagian Ilmu Kedokteran Jiwa, Fakultas Kedokteran, Universitas Gadjah
Mada, Yogyakarta, 2001
36. Wechsler D. Wechsler intelligence scale for children, 3rd ed. New York: Hardcourt Brace
Jovanovich, Inc, 1992
37. John, Ahn, Prichep, Trepetin, Brown, Kaye. Developmental Equations for the
Electroencephalogram, Science, 1980, vol. 210, 1255-1258
38. Kyngas H. Predictors of Good Compliance in Therapy, Seizure, 2001, 10: 549-553
39. Prawirohartono. Mempelajari Biostatistik secara Mudah, Bagian Ilmu Kesehatan Anak,
Fakultas Kedokteran Universitas Gadjah Mada, RS. Dr. Sardjito, Yogyakarta, 2000
40. Pusorowati. Manajemen Data, Analisa Data Kesehatan, Pelatihan Analisa Data
Kesehatan, Clinical Epidemiology and Biostatistic Unit, Fakultas Kedokteran, RS Dr.
Sardjito, Gadjah Mada University, Yogyakarta, 2002
41. Murti B. Prinsip dan Metode Riset Epidemiologi, Gadjah Mada University Press, 1997
42. El-Sayed E. M. Brain Maturation, Cognitive Tasks, and Quantitative
Electroencephalography: A Study in Children with Attention Deficit Hyperactivity
Disorder, Karolinska Institutet, Department of Woman and Child Health, Child and
Adolescent Psichiatric Unit, Stockholm, 2002
43. Barkley R. A., Anastopoulos A. D., Guevremont D. G., Fletcher K. F. Adolescents with
attention deficit hyperactivity disorder: Mother–adolescent interactions, family beliefs and
conflicts, and maternal psychopathology. Journal of Abnormal Child Psychology, 1992,
20, 263–288
44. Clark C., Prior M., Kinsella G. J. Do executive function deficits differentiate between
adolescents with ADHD and oppositional defiant/conduct disorder?: A
neuropsychological study using the Six Elements Test and Hayling Sentence Completion
Test. Journal of Abnormal Child Psychology, 2000, 28, 405–414 
28
45. Rasmussen P. Natural outcome of ADHD with developmental coordination disorder at
age 22 years: a controlled, longitudinal, community-based study, J Am Acad Child
Adolesc Psychiatry, 2000, 39(11):1424-1431
46. Satterfield J., Cantwell D., Saul R., Lesser M., Podsin R. Response to stimulant drug
treatment in hyperactive children: predictions from EEG and neurological findings, J
Autism Child Schizophr, 1973, 3:36–48
47. Levy F., Swanson J. M. Timing, space and ADHD: the dopamine theory Revisited,
Australian and New Zealand Journal of Psychiatry, 2001, 35:504–511
48. Larry S. M. The Use of Auditory and Visual Stimulation for the Treatment of Attention
Deficit Hyperactivity Disorder in Children, Dissertation Doctor of Philosophy in Social
Work in the Graduate School of Social Work of the University of Houston, Texas, 1999
49. Solanto M. Dopamine Dysregulation in AD/HD: Integrating Clinical and Basic Science
Research, makalah dalam 6th Internet Worlds Conggres for Biomedical Sciences, Inabis
2000, 2000
50. Laupacis A., Wells G., Richardson S., Tugwell P. User’s Guide to The Medical Literature:
How to Use an Article about Prognosis, JAMA, 1994, 272(3); 234-237
citation:   Pandhita, Gea  (2005) GAMBARAN QUANTITATIVE ELECTROENCEPHALOGRAPHY (QEEG) SEBAGAI PREDIKTOR RESPON TERAPI METHYLPHENIDATE DALAM PENATALAKSANAAN ATTENTION-DEFICIT / HYPERACTIVITY DISORDER (ADHD) PADA ANAK.  Masters thesis, Gadjah Mada University.   
document_url: http://repository.uhamka.ac.id/id/eprint/11460/1/Naskah%20Ringkasan%20Program%20Pendidikan%20Dokter%20Spesialis.pdf